Rituximab-induced late-onset neutropenia

BMJ Case Rep. 2019 Dec 29;12(12):e233569. doi: 10.1136/bcr-2019-233569.

Authors

Kamal Kant Sahu¹, Nathan Petrou², Zachary Cohn², Shrinkhala Khanna²

Affiliations

¹ Department of Internal Medicine, Saint Vincent Hospital, Worcester, Massachusetts, USA drkksahu85@gmail.com.
² Department of Medicine, Division of Hematology/Oncology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.

No abstract available

Keywords: haematology (drugs and medicines); infections; neurology (drugs and medicines).

Publication types

Case Reports

MeSH terms

Adult
Anti-Bacterial Agents / therapeutic use
Female
Granulocyte Colony-Stimulating Factor / therapeutic use
Humans
Multiple Sclerosis / drug therapy
Neutropenia / chemically induced*
Neutropenia / drug therapy
Rituximab / adverse effects*

Substances

Anti-Bacterial Agents
Granulocyte Colony-Stimulating Factor
Rituximab